Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China
· Delayed Price · Currency is CNY 11.84
-0.04 (-0.34%)
Apr 30, 2025, 3:00 PM CST
SHA:603439 Market Cap
SHA:603439 has a market cap or net worth of 4.74 billion as of May 2, 2025. Its market cap has decreased by -28.65% in one year.
Market Cap
4.74B
Enterprise Value
5.13B
Revenue
2.13B
Ranking
n/a
PE Ratio
18.85
Stock Price
11.84
Market Cap Chart
Since April 28, 2020, SHA:603439's market cap has increased from 4.31B to 4.74B, an increase of 10.00%. That is a compound annual growth rate of 1.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2025 | 4.74B | -8.92% |
| Dec 31, 2024 | 5.20B | -32.74% |
| Dec 29, 2023 | 7.74B | 37.27% |
| Dec 30, 2022 | 5.64B | -13.05% |
| Dec 31, 2021 | 6.48B | -21.44% |
| Dec 31, 2020 | 8.25B | 91.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 324.92B |
| Shenzhen Mindray Bio-Medical Electronics | 265.66B |
| WuXi AppTec | 168.50B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.88B |
| Aier Eye Hospital Group | 120.68B |
| Sichuan Biokin Pharmaceutical | 114.72B |
| Shanghai United Imaging Healthcare | 108.98B |
| Yunnan Baiyao Group Co.,Ltd | 102.18B |